Dual Synthetic Peptide Conjugate Vaccine Simultaneously Triggers TLR2 and NOD2 and Activates Human Dendritic Cells

Abstract

Simultaneous triggering of Toll-like receptors (TLRs) and NOD-like receptors (NLRs) has previously been shown to synergistically activate monocytes, dendritic cells, and macrophages. We applied these properties in a T-cell vaccine setting by conjugating the NOD2-ligand muramyl-dipeptide (MDP) and TLR2-ligand Pam3CSK4 to a synthetic peptide derived from a model antigen. Stimulation of human DCs with the MDP-peptide-Pam3CSK4 conjugate led to a strongly increased secretion of pro-inflammatory and Th1-type cytokines and chemokines. We further show that the conjugated ligands retain their ability to trigger their respective receptors, while even improving NOD2-triggering. Also, activation of murine DCs was enhanced by the dual triggering, ultimately leading to effective induction of vaccine-specific T cells expressing IFNγ, IL-2, and TNFα. Together, these data indicate that the dual MDP-SLP-Pam3CSK4 conjugate constitutes a chemically well-defined vaccine approach that holds promise for the use in the treatment of virus infections and cancer.

Systematic Dual Targeting of Dendritic Cell C-Type Lectin Receptor DC-SIGN and TLR7 Using a Trifunctional Mannosylated Antigen

“…Another approach for the development of well-defined anti-cancer vaccines entails the covalent attachment of other adjuvants to the antigens of choice, targeting other Pattern Recognition Receptors (PRR), such as members of the Toll-Like Receptor (TLR) family (Deres et al, 1989; Cho et al, 2000; Blander and Medzhitov, 2006; Fujita and Taguchi, 2012; Willems et al, 2014), the NOD-like receptor (NLR) family (Willems et al, 2016), or combinations thereof (Buskas et al, 2005; Moyle et al, 2007; Sedaghat et al, 2016; Zom et al, 2019). PAMP recognition by TLRs induces DC maturation, stimulating antigen processing, and presentation for the induction of pathogen-specific T cells (Ackerman and Cresswell, 2003).…”

Adamantane Containing Peptidoglycan Fragments Enhance RANTES and IL-6 Production in Lipopolysaccharide-Induced Macrophages

“…Combinations of PRR ligands, such as PGN fragments and LPS, enable NLR/TLR crosstalk resulting in the modulation of innate and adaptive immune responses [27]. The application of multi-PRR activation approaches can significantly increase immunity and presents a new approach for the design of novel vaccines [28].…”

Emerging Adjuvants for Cancer Immunotherapy

“…In recent years, Kahn's group focused on exploring covalently linked TLR agonists, such as dimeric (covalently coupled TLR2 and TLR9 heterodimers) (Mancini et al, 2014 ) and trimeric agonists (TLR4, TLR7, and TLR9 covalently linked agonists) (Tom et al, 2015 ) agonists. Zom et al ( 2019 ) synthesized a peptide conjugate that could simultaneously trigger the NOD2 and TLR2 signaling pathways and enhance the production of TNF-α, IFN-γ, and IL-2 by murine T cells (Zom et al, 2019 ). Exploration of the different TLR combinations required for the synthesis of various di- or tri-agonists is the major challenge.…”